Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Burosumab in Patients Less Than 1 Year of Age
Clinical trial NCT04188964 · COMPLETED
Trial details
- NCT number
- NCT04188964
- Sponsor
- Kyowa Kirin Pharmaceutical Development Ltd
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-26
- Primary completion
- 2023-10-04
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.